Dr. Parth Verma
Consultant Oncologist and Cancer Specialist in Surat, with comprehensive all-site practice and advanced fellowship training in Urogenital Oncology from Tata Memorial Hospital, Mumbai.
Rigorous Academic Foundation & Subspecialty Oncology Expertise
Dr. Parth Verma is a Consultant Oncologist and Cancer Specialist practicing in Surat, Gujarat. He completed his post-graduate residency in MD Radiation Oncology at the renowned Amrita Institute of Medical Sciences (AIMS), Kochi, acquiring extensive clinical expertise in comprehensive cancer management, diagnosis, staging, and advanced precision radiotherapy across all major cancer types.
He subsequently completed advanced fellowship training in Urogenital Oncology at Tata Memorial Hospital / ACTREC (Mumbai), India's premier apex cancer institution. His fellowship training focused on specialized treatments for prostate cancer (including 5-session Prostate SBRT), organ-preserving bladder protocols (Trimodality Therapy), kidney SABR, and multidisciplinary cancer care.
Comprehensive All-Site Radiotherapy with Subspecialty Depth
Combining modern technological delivery with empathetic, patient-centered decision making.
Urogenital Radiation Oncology
Specialized Tata Memorial Hospital fellowship training in prostate cancer (SBRT & VMAT), organ-preserving bladder cancer radiotherapy, kidney SABR, and testicular/penile malignancies.
Stereotactic Radiotherapy (SRS & SBRT)
Sub-millimeter ablative radiotherapy for primary tumors and oligometastatic lesions in the lung, liver, spine, brain, and bones, delivered in 1 to 5 painless outpatient sessions.
Motion Management & Heart Protection
Deep Inspiration Breath Hold (DIBH) for left-sided breast cancer and 4D-CT respiratory gating for thoracic and upper abdominal tumors to shield vital organs.
Comprehensive All-Site Oncology
Definitive and adjuvant radiotherapy for Head & Neck, Gynecological (Cervix/Uterus), Gastrointestinal (Rectum/Esophagus), and Brain tumors.
International Oncology Conferences & Research
Dr. Parth Verma presenting peer-reviewed clinical research and clinical trial data at leading international oncology congresses.
ESTRO CongressOligometastatic Prostate Cancer: PSMA PET Response
“PSMA PET response vs PSA nadir with ADT & ARPI in de-novo oligometastatic hormone sensitive prostate cancer.”
Tata Memorial Hospital & ACTREC, Mumbai
ESMO BarcelonaHigh-Risk Endometrial Cancer (PORTEC-3 Regimen)
“Treatment Outcomes and Toxicity Profiles in South Asian patients of High-Risk Endometrial Cancer treated with PORTEC-3 trial regimen.”
Amrita Institute of Medical Sciences (AIMS), Kochi
ESMO Asia SingaporeHead & Neck Oncology: p16 Positivity & Outcomes
“Oropharyngeal Squamous Cell Carcinomas in Indian Population - p16 Positivity and Treatment Outcomes Following Chemoradiotherapy.”
Amrita Institute of Medical Sciences (AIMS), KochiExplore Full Publications on ResearchGate
Access Dr. Verma's full-text research papers, co-authored clinical studies, and presentation abstracts.
Schedule a Consultation in Surat
Available for in-person consultations in Surat as well as online tele-consultations for second opinions.